Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23803)

Formulation Name

Lefamulin 150 mg Injection

Company

Nabriva Therapeutics Us

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lefamulin	DME6G97	Community-acquired pneumonia	CA40.Z	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Kyselina citronova	E00014	311	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Sodium chloride	E00077	5234	Diluent; Tonicity agent
Sodium citrate dihydrate	E00369	71474	Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Water	E00035	962	Solvent

--------------------